Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SPY, TPTX, PRNB, CCXI, RETA, and represent 34.01% of Cormorant Asset Management's stock portfolio.
  • Added to shares of these 10 stocks: SPY (+$257.75M), XLRN (+$74.14M), RVMD (+$60.63M), AGEN (+$29.83M), EIDX (+$29.61M), IGMS (+$15.14M), BEAM (+$14.34M), OMER (+$13.35M), BBIO (+$12.68M), ANAB (+$10.50M).
  • Started 9 new stock positions in BEAM, XLRN, RVMD, AGEN, INSM, FATE, ARCT, SPY, FIXX.
  • Reduced shares in these 10 stocks: , RETA (-$47.52M), MRTX (-$33.24M), BHVN (-$21.25M), CCXI (-$20.09M), CRSP (-$15.67M), TPTX (-$15.18M), Ra Pharmaceuticals (-$13.87M), APLS (-$11.62M), AXNX (-$10.74M).
  • Sold out of its positions in Ra Pharmaceuticals, XBI.
  • Cormorant Asset Management was a net buyer of stock by $250.30M.
  • Cormorant Asset Management has $2.15B in assets under management (AUM), dropping by -14.12%.

Portfolio Holdings for Cormorant Asset Management

Companies in the Cormorant Asset Management portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
SPDR S&P 500 ETF (SPY) 11.98 1.00M NEW 257.75
Turning Point Therapeutics I (TPTX) 6.34 3.06M -10% 44.66
Principia Biopharma (PRNB) 5.79 2.10M +5% 59.38
Chemocentryx (CCXI) 4.95 2.65M -15% 40.18
Reata Pharmaceuticals Inc Cl A (RETA) 4.94 737.21k -30% 144.34
Mirati Therapeutics (MRTX) 4.82 1.35M -24% 76.87
Bridgebio Pharma (BBIO) 3.98 2.95M +17% 29.00
Acceleron Pharma (XLRN) 3.45 825.00k NEW 89.87
Ascendis Pharma A S (ASND) 3.14 600.00k -7% 112.61
Viela Bio (VIE) 3.11 1.76M +17% 38.00
Constellation Pharmceticls I (CNST) 2.98 2.04M -11% 31.43
Apellis Pharmaceuticals (APLS) 2.82 2.27M -16% 26.79
Revolution Medicines (RVMD) 2.82 2.77M NEW 21.91
Eidos Therapeutics (EIDX) 2.50 1.10M +121% 48.99
Y Mabs Therapeutics (YMAB) 2.10 1.73M +8% 26.10
Stoke Therapeutics (STOK) 1.82 1.71M -4% 22.90
Omeros Corporation (OMER) 1.57 2.52M +65% 13.37
Myokardia (MYOK) 1.52 700.00k 46.88
Agenus (AGEN) 1.39 12.17M NEW 2.45
Biohaven Pharmaceutical Holding (BHVN) 1.38 875.55k -41% 34.03
Axsome Therapeutics (AXSM) 1.37 500.00k -16% 58.83
Nextcure (NXTC) 1.28 743.40k -25% 37.07
Crispr Therapeutics (CRSP) 1.24 630.40k -36% 42.41
Blueprint Medicines (BPMC) 1.22 450.00k +30% 58.48
Zymeworks (ZYME) 1.15 700.00k 35.47
Igm Biosciences (IGMS) 1.11 426.10k +172% 56.15
Rocket Pharmaceuticals (RCKT) 1.02 1.57M -14% 13.95
Twist Bioscience Corp (TWST) 0.98 687.15k 30.58
Axonics Modulation Technolog (AXNX) 0.94 800.00k -34% 25.41
Galapagos Nv-spon (GLPG) 0.91 98.60k 199.60
Myovant Sciences (MYOV) 0.91 2.60M +30% 7.55
Immunovant Inc unit 12/18/2024 (IMVTU) 0.90 1.08M 17.99
Tricida (TCDA) 0.90 877.98k -5% 22.00
Satsuma Pharmaceuticals Ord (STSA) 0.81 808.38k -5% 21.52
Anaptysbio Inc Common (ANAB) 0.73 1.11M +203% 14.13
Cabaletta Bio (CABA) 0.71 2.11M 7.30
Zai Lab (ZLAB) 0.69 289.09k +4% 51.48
Sarepta Therapeutics (SRPT) 0.68 150.00k -40% 97.82
Deciphera Pharmaceuticals (DCPH) 0.67 350.00k -22% 41.17
Beam Therapeutics (BEAM) 0.67 796.43k NEW 18.00
Akero Therapeutics (AKRO) 0.63 642.54k -13% 21.20
Quotient (QTNT) 0.58 3.16M -9% 3.95
Uniqure Nv (QURE) 0.55 250.00k -37% 47.45
Argenx Se (ARGX) 0.49 80.00k -20% 131.72
Homology Medicines (FIXX) 0.43 600.00k NEW 15.54
Sorrento Therapeutics (SRNE) 0.43 5.00M +25% 1.84
Inspire Med Sys (INSP) 0.42 150.00k -12% 60.28
Allakos (ALLK) 0.41 200.00k -33% 44.49
Kura Oncology (KURA) 0.37 800.00k -20% 9.95
Harpoon Therapeutics (HARP) 0.35 649.99k 11.58
Merus N V (MRUS) 0.34 600.00k -40% 12.10
Insmed (INSM) 0.27 362.27k NEW 16.03
Eiger Biopharmaceuticals (EIGR) 0.26 815.13k -2% 6.80
Atreca Inc Cl A (BCEL) 0.25 326.14k 16.55
Avrobio Ord (AVRO) 0.23 317.58k 15.56
Arena Pharmaceuticals (ARNA) 0.20 100.00k -41% 42.00
Minerva Neurosciences (NERV) 0.17 607.90k 6.02
Amarin Corporation (AMRN) 0.17 900.00k -30% 4.00
Arcturus Therapeutics Hldg I (ARCT) 0.17 262.04k NEW 13.59
X4 Pharmaceuticals (XFOR) 0.16 341.62k +35% 10.00
Autolus Therapeutics Plc spon ads (AUTL) 0.13 479.99k 5.99
Nektar Therapeutics (NKTR) 0.12 150.00k -25% 17.85
Theravance Biopharma (TBPH) 0.11 100.00k +100% 23.11
Neurocrine Biosciences (NBIX) 0.10 25.00k -36% 86.56
Precision Biosciences Ord (DTIL) 0.10 346.52k -25% 6.03
Gossamer Bio (GOSS) 0.09 198.38k -33% 10.15
Orchard Therapeutics Plc ads (ORTX) 0.09 256.65k -26% 7.53
Fate Therapeutics (FATE) 0.08 75.00k NEW 22.21
Outlook Therapeutics Inc *w exp 02/18/201 (OTLKW) 0.00 416.67k 0.16

Past Filings by Cormorant Asset Management

View past SEC 13F filings by Cormorant Asset Management

View all filings